An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease
Article in Neurobiology of Disease (June 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Neurobiology of Disease (June 2024)
Preprint in bioRxiv (February 2024)
Article in Cellular Signalling (January 2024)